Group One Trading
CLOV icon

Group One Trading’s Clover Health Investments CLOV Stock Holding History

Group One Trading’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$534K Sell
303,600
-237,800
-44% -$516K ﹤0.01% 3285
2025
Q4 		$1.27M Buy
541,400
+147,600
+37% +$403K ﹤0.01% 2685
2025
Q3 		$1.21M Buy
393,800
+110,100
+39% +$314K ﹤0.01% 2832
2025
Q2 		$792K Buy
283,700
+16,700
+6% +$54.9K ﹤0.01% 2981
2025
Q1 		$959K Sell
267,000
-70,900
-21% -$285K ﹤0.01% 2499
2024
Q4 		$1.06M Buy
337,900
+88,300
+35% +$316K ﹤0.01% 2520
2024
Q3 		$704K Buy
249,600
+161,200
+182% +$369K ﹤0.01% 2595
2024
Q2 		$109K Buy
88,400
+55,400
+168% +$49.7K ﹤0.01% 3903
2024
Q1 		$26.2K Sell
33,000
-297,700
-90% -$271K ﹤0.01% 5230
2023
Q4 		$315K Buy
330,700
+265,400
+406% +$261K ﹤0.01% 3472
2023
Q3 		$70.5K Buy
65,300
+8,700
+15% +$10.3K ﹤0.01% 4784
2023
Q2 		$50.8K Sell
56,600
-9,000
-14% -$7.98K ﹤0.01% 5260
2023
Q1 		$55.4K Buy
65,600
+47,500
+262% +$52K ﹤0.01% 4771
2022
Q4 		$16.8K Sell
18,100
-69,400
-79% -$92.6K ﹤0.01% 5707
2022
Q3 		$149K Buy
87,500
+1,300
+2% +$3.4K ﹤0.01% 4415
2022
Q2 		$184K Sell
86,200
-67,900
-44% -$180K ﹤0.01% 4384
2022
Q1 		$547K Sell
154,100
-38,700
-20% -$112K ﹤0.01% 3712
2021
Q4 		$717K Sell
192,800
-1,233,100
-86% -$7.56M ﹤0.01% 3700
2021
Q3 		$10.5M Buy
1,425,900
+551,200
+63% +$4.72M 0.01% 1029
2021
Q2 		$11.7M Buy
874,700
+217,100
+33% +$2.13M 0.01% 963
2021
Q1 		$4.97M Sell
657,600
-527,200
-44% -$5.95M 0.01% 1515
2020
Q4 		$19.9M Buy
+1,184,800
New +$13.2M 0.03% 449

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading's CLOV Position: Q1 2026 in Review

Group One Trading reduced its Clover Health Investments (CLOV) stake by 46% in Q1 2026, selling an estimated $1.09M and leaving 587,104 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

Group One Trading first reported a position in CLOV in Q4 2020 and has held it in 19 quarters since. The position peaked at $32.1M in Q4 2020. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Group One Trading held 587,104 shares of Clover Health Investments worth $1.03M as of Q1 2026.
  • Group One Trading sold 500,871 Clover Health Investments shares in Q1 2026, an estimated $1.09M.
  • Clover Health Investments made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2685 holding.
  • Group One Trading first reported a position in Clover Health Investments in Q4 2020 and has held it in 19 quarters since.
  • Group One Trading's Clover Health Investments position peaked at $32.1M in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.